• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Johnson & Johnson (NY:JNJ)

    244.02 +0.69 (+0.28%)
    Streaming Delayed Price Updated: 1:09 PM EST, Feb 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,431,442
    Open 243.24
    Bid (Size) 244.00 (300)
    Ask (Size) 244.03 (100)
    Prev. Close 243.33
    Today's Range 242.82 - 244.61
    52wk Range 141.50 - 246.35
    Shares Outstanding 2,628,679,824
    Dividend Yield 2.13%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Health Care Sector (XLV) Shows Resilience Amid Tech Volatility and Strong Jobs Data
    As the broader market grappled with a violent valuation reset in the technology sector, the health care industry emerged as a critical anchor for investors in early 2026. The Health Care Select Sector... 
    Via MarketMinute
    Topics Artificial Intelligence ETFs Earnings
    News headline image
    Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
    From Johnson & Johnson
    Via Business Wire

    Performance

    YTD
    +17.7%
    +17.7%
    1 Month
    +11.8%
    +11.8%
    3 Month
    +22.0%
    +22.0%
    6 Month
    +37.2%
    +37.2%
    1 Year
    +57.4%
    +57.4%

    More News

    Read More
    News headline image
    FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer ↗
    Via Benzinga
    Johnson & Johnson (NYSE:JNJ) Stands Out as a High-Quality Dividend Aristocrat for Income Investors ↗
    Via Chartmill
    News headline image
    Behind the Scenes of Johnson & Johnson's Latest Options Trends ↗
    Via Benzinga
    News headline image
    Johnson & Johnson's New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner ↗
    Via Benzinga
    News headline image
    Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
    From BioMedWire
    Via GlobeNewswire
    News headline image
    The Seven-Thousand Siege: S&P 500’s Historic Breach and the Great Tech Pivot of 2026
    Via MarketMinute
    Topics Artificial Intelligence ETFs Earnings
    News headline image
    ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Jury: Johnson & Johnson Liabile in Case Linking Baby Powder to Cancer ↗
    Via Benzinga
    News headline image
    Philadelphia Jury Returns $250,000 Verdict Against J&J in Latest Baby Powder-Ovarian Cancer Trial
    From Beasley Allen Law Firm
    Via Business Wire
    News headline image
    Volatility Returns to Wall Street: VIX Surges 18% as AI Fatigue Triggers Massive Three-Day Sector Rotation
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    News headline image
    "Blowout" Jobs Report Ignites 2026 Growth Hopes as Unemployment Hits 4.3% Floor
    Via MarketMinute
    Topics Artificial Intelligence Economy Workforce
    News headline image
    The Great Rebound: US M&A Market Ignites as Megadeals Surge 111% in AI-Driven Supercycle
    Via MarketMinute
    Topics Artificial Intelligence Economy Energy
    News headline image
    Is Johnson & Johnson a Buy, Sell, or Hold in 2026? ↗
    Via The Motley Fool
    Topics Artificial Intelligence Intellectual Property Lawsuit
    News headline image
    Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
    Via FinancialNewsMedia
    News headline image
    Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference
    From Johnson & Johnson
    Via Business Wire
    News headline image
    5 Stocks and ETFs to Help Shield Your Portfolio During Volatility ↗
    Via MarketBeat
    Topics ETFs
    News headline image
    Johnson & Johnson Reports 90% AFib Freedom In Early Heart Device Study ↗
    Via Benzinga
    News headline image
    What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill. ↗
    Via The Motley Fool
    Topics Bonds
    News headline image
    Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium
    From Johnson & Johnson
    Via Business Wire
    News headline image
    Eli Lilly Booms, Then Busts: Stellar Guidance vs Hims Undercut ↗
    Via MarketBeat
    News headline image
    Johnson & Johnson Is A Resilient Blue-Chip Stock And It Just Hit New All-Time Highs ↗
    Via Talk Markets
    News headline image
    Johnson & Johnson Is a Resilient Blue-Chip Stock and It Just Hit New All-Time Highs
    Via Barchart.com
    News headline image
    The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property

    Frequently Asked Questions

    Is Johnson & Johnson publicly traded?
    Yes, Johnson & Johnson is publicly traded.
    What exchange does Johnson & Johnson trade on?
    Johnson & Johnson trades on the New York Stock Exchange
    What is the ticker symbol for Johnson & Johnson?
    The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
    What is the current price of Johnson & Johnson?
    The current price of Johnson & Johnson is 244.02
    When was Johnson & Johnson last traded?
    The last trade of Johnson & Johnson was at 02/18/26 01:09 PM ET
    What is the market capitalization of Johnson & Johnson?
    The market capitalization of Johnson & Johnson is 641.45B
    How many shares of Johnson & Johnson are outstanding?
    Johnson & Johnson has 641B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.